NPR's Richard Harris reports that a small company in North Carolina is pioneering a new approach in its attempt to develop a vaccine against AIDS. Scientists have tapped public money and a charity, as well as venture capital, to move an intriguing idea from the laboratory toward the marketplace. Untraditional approaches like this seem to be needed to surmount the many technical and practical difficulties in developing an AIDS vaccine.
Copyright 2000 NPR
